CVR number 37324256
Industry 869500

Autoriserede fysioterapeuter i Brande ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.9% 4.5% 4.8% 6.0% 5.5%  
Credit score (0-100)  35 45 44 38 41  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  926 1,731 1,453 1,476 1,527  
EBITDA  228 319 268 188 288  
EBIT  192 283 232 152 245  
Pre-tax profit (PTP)  143.6 243.8 153.6 71.4 144.5  
Net earnings  101.9 181.1 111.8 47.4 103.4  
Pre-tax profit without non-rec. items  144 244 154 71.4 144  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  2,182 2,146 2,110 2,074 2,138  
Shareholders equity total  595 716 737 725 828  
Interest-bearing liabilities  1,433 1,321 1,354 1,319 1,375  
Balance sheet total (assets)  2,399 2,366 2,261 2,267 2,422  
Net Debt  1,385 1,283 1,291 1,319 1,371  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  926 1,731 1,453 1,476 1,527  
Gross profit growth  -0.3% 86.8% -16.0% 1.6% 3.5%  
Employees  2 2 3 4 4  
Employee growth %  0.0% 0.0% 50.0% 33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,399 2,366 2,261 2,267 2,422  
Balance sheet change%  1.8% -1.4% -4.4% 0.3% 6.8%  
Added value  228.2 319.5 268.0 188.5 287.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -72 -72 -72 -72 22  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  20.7% 16.4% 16.0% 10.3% 16.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.1% 11.9% 10.0% 6.7% 10.5%  
ROI %  9.0% 13.9% 11.2% 7.4% 11.5%  
ROE %  17.3% 27.6% 15.4% 6.5% 13.3%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  24.8% 30.3% 32.6% 32.0% 34.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  606.7% 401.6% 481.6% 699.9% 476.6%  
Gearing %  241.0% 184.6% 183.6% 182.0% 166.0%  
Net interest  0 0 0 0 0  
Financing costs %  3.2% 2.9% 5.9% 6.1% 7.5%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.3 0.3 0.6 0.5 0.6  
Current Ratio  0.3 0.3 0.6 0.5 0.6  
Cash and cash equivalent  48.6 38.1 63.3 0.0 3.7  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -615.6 -534.9 -110.6 -179.0 -227.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  114 160 89 47 72  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  114 160 89 47 72  
EBIT / employee  96 142 77 38 61  
Net earnings / employee  51 91 37 12 26